Review Article| Volume 5, ISSUE 1, P255-266, May 2023

Download started.


Attention-Deficit/Hyperactivity Disorder Update 2022

New Medications Are Here!


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Advances in Family Practice Nursing
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


      1. Children and Adults with Attention Deficit Disorder (CHADD). ADHD Data and Statistics. General Prevalence of ADHD.
        (Available at:)
        • Danielson M.L.
        • Bitsko R.H.
        • Ghandour R.M.
        • et al.
        Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among US Children and Adolescents, 2016.
        J Clin Child Adolesc Psychol. 2018;
        • Stein R.E.K.
        • Storfer-Isser A.
        • Kerker B.D.
        • et al.
        Beyond ADHD: how well are we doing?.
        Acad Pediatr. 2016; 16: 115-121
        • Wolraich M.L.
        • Hagan J.F.
        • Allan C.
        • et al.
        Clinical Practice Guideline for the Diagnosis, Evaluation and Treatment of Attention-Deficit/Hyperactivty Disorder in Children and Adolescents.
        Pediatrics. 2019; 144 (Available at:)
        • Nguyen M.
        • Tharani S.
        • Rahmani M.
        • et al.
        A review of the use of clonidine as a sleep aid in the child and adolescent population.
        Clin Pediatr. 2014; 53: 211-216
      2. Aytu BioPharma. Adzenys.
        (Available at:)
        • Stewart J.
        (Available at:)
      3. Takeda Pharmaceuticals. Mydais.
        (Available at:)
      4. Aptensio.
        (Available at:)
        • Stewart J.
        (Available at:)
      5. Ironshore Pharmaceuticals. Jornay.
        (Available at:)
      6. Associated Press. FDA approves 1st new ADHD drug for kids in over a decade. Today.
        (Available at:)
      7. Supernus Pharmaceuticals. Qelbree.
        (Available at:)
      8. Cohen Children’s Medical Center. ADHD Medication Guide.
        (Available at:)
        • Harrison M.E.
        • Norris M.L.
        • Robinson A.
        • et al.
        Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review.
        Appetite. 2019; 137: 62-72
      9. Vanderbilt Scales.
        (Available at:)